会议专题

Addition of cilostazol to conventional dual antiplatelet therapy reducing the risk of cardiac events and restenosis after drugeluting stent implantation:a metaanalysis

Backgrounds Relative efficacy and safety of triple antiplatelet therapy(TAT,addition of cilostazol to aspirin and clopidogrel)compared with conventional dual antiplatelet therapy(DAT,aspirin and clopidogrel)remained controversial.Objectives This meta-analysis was performed to compare the risk of cardiac events and restenosis of TAT versus DAT in drug-eluting stents(DES)implantation patients.

Zhangwei Chen

Zhongshan Hospital Affilated to Fudan University,Shanghai 200032,China

国内会议

第14届中国南方国际心血管病学术会议

广州

英文

179-179

2012-04-11(万方平台首次上网日期,不代表论文的发表时间)